Spartan Fund Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-226,753
Closed -$2.24M 547
2022
Q2
$2.24M Hold
226,753
0.48% 55
2022
Q1
$2.79M Buy
+226,753
New +$2.23M 0.46% 58

Other funds holding LUXA

Spartan Fund Management's LUXA Position: Q3 2022 in Review

Spartan Fund Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q3 2022, closing a stake of 226,753 shares — an estimated $2.24M sold.

Spartan Fund Management first reported a position in LUXA in Q1 2022 and held it in 2 quarters. The position peaked at $2.79M in Q1 2022. 72 funds tracked by Wall St. Rank hold LUXA as of Q3 2022.

  • Spartan Fund Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Spartan Fund Management sold 226,753 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $2.24M.
  • Spartan Fund Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Spartan Fund Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.79M in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Spartan Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.